Open AccessDoxorubicin-eluting beadvsconventional transcatheter arterial chemoembolization for hepatocellular carcinoma before liver transplantation
Author(s) -
Daniele Nicolini,
Gianluca Svegliati–Baroni,
Roberto Candelari,
Cinzia Mincarelli,
Alessandra Mandolesi,
Italo Bearzi,
Federico Mocchegiani,
Andrea Vecchi,
Roberto Montalti,
Antonio Benedetti,
Andrea Risaliti,
Marco Vivarelli
Publication year - 2013
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v19.i34.5622
Subject(s) - medicine , hepatocellular carcinoma , liver transplantation , transcatheter arterial chemoembolization , percutaneous ethanol injection , radiofrequency ablation , milan criteria , transplantation , nodule (geology) , necrosis , radiology , gastroenterology , ablation , paleontology , biology
To assess the possible effect of two different types of preoperative transcatheter arterial chemoembolization (TACE) on recurrence-free survival after liver transplantation (LT) in patients with hepatocellular carcinoma (HCC) and to analyze the effects of TACE on tumor histology.